Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Natural Killer Cell Therapies market report explains the definition, types, applications, major countries, and major players of the Natural Killer Cell Therapies market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Innate
Fortress Biotech
Dragonfly Therapeutics
NantWorks
Nkarta Therapeutics
Affimed
Chipscreen Biosciences
Glycostem
Fate Therapeutics
Kiadis Pharma
Nektar Therapeutics
By Type:
NK Cell Therapies
NK Cell Directed Antibodies
By End-User:
Cancer
Gastrointestinal Diseases
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Natural Killer Cell Therapies Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Natural Killer Cell Therapies Outlook to 2028- Original Forecasts
-
2.2 Natural Killer Cell Therapies Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Natural Killer Cell Therapies Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Natural Killer Cell Therapies Market- Recent Developments
-
6.1 Natural Killer Cell Therapies Market News and Developments
-
6.2 Natural Killer Cell Therapies Market Deals Landscape
7 Natural Killer Cell Therapies Raw Materials and Cost Structure Analysis
-
7.1 Natural Killer Cell Therapies Key Raw Materials
-
7.2 Natural Killer Cell Therapies Price Trend of Key Raw Materials
-
7.3 Natural Killer Cell Therapies Key Suppliers of Raw Materials
-
7.4 Natural Killer Cell Therapies Market Concentration Rate of Raw Materials
-
7.5 Natural Killer Cell Therapies Cost Structure Analysis
-
7.5.1 Natural Killer Cell Therapies Raw Materials Analysis
-
7.5.2 Natural Killer Cell Therapies Labor Cost Analysis
-
7.5.3 Natural Killer Cell Therapies Manufacturing Expenses Analysis
8 Global Natural Killer Cell Therapies Import and Export Analysis (Top 10 Countries)
-
8.1 Global Natural Killer Cell Therapies Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Natural Killer Cell Therapies Export by Region (Top 10 Countries) (2017-2028)
9 Global Natural Killer Cell Therapies Market Outlook by Types and Applications to 2022
-
9.1 Global Natural Killer Cell Therapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global NK Cell Therapies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global NK Cell Directed Antibodies Consumption and Growth Rate (2017-2022)
-
9.2 Global Natural Killer Cell Therapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Natural Killer Cell Therapies Market Analysis and Outlook till 2022
-
10.1 Global Natural Killer Cell Therapies Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Natural Killer Cell Therapies Consumption (2017-2022)
-
10.2.2 Canada Natural Killer Cell Therapies Consumption (2017-2022)
-
10.2.3 Mexico Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.2 UK Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.3 Spain Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.4 Belgium Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.5 France Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.6 Italy Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.7 Denmark Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.8 Finland Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.9 Norway Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.10 Sweden Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.11 Poland Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.12 Russia Natural Killer Cell Therapies Consumption (2017-2022)
-
10.3.13 Turkey Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.2 Japan Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.3 India Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.4 South Korea Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.5 Pakistan Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.6 Bangladesh Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.7 Indonesia Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.8 Thailand Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.9 Singapore Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.10 Malaysia Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.11 Philippines Natural Killer Cell Therapies Consumption (2017-2022)
-
10.4.12 Vietnam Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5.2 Colombia Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5.3 Chile Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5.4 Argentina Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5.5 Venezuela Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5.6 Peru Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5.7 Puerto Rico Natural Killer Cell Therapies Consumption (2017-2022)
-
10.5.8 Ecuador Natural Killer Cell Therapies Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Natural Killer Cell Therapies Consumption (2017-2022)
-
10.6.2 Kuwait Natural Killer Cell Therapies Consumption (2017-2022)
-
10.6.3 Oman Natural Killer Cell Therapies Consumption (2017-2022)
-
10.6.4 Qatar Natural Killer Cell Therapies Consumption (2017-2022)
-
10.6.5 Saudi Arabia Natural Killer Cell Therapies Consumption (2017-2022)
-
10.6.6 United Arab Emirates Natural Killer Cell Therapies Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Natural Killer Cell Therapies Consumption (2017-2022)
-
10.7.2 South Africa Natural Killer Cell Therapies Consumption (2017-2022)
-
10.7.3 Egypt Natural Killer Cell Therapies Consumption (2017-2022)
-
10.7.4 Algeria Natural Killer Cell Therapies Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Natural Killer Cell Therapies Consumption (2017-2022)
-
10.8.2 New Zealand Natural Killer Cell Therapies Consumption (2017-2022)
11 Global Natural Killer Cell Therapies Competitive Analysis
-
11.1 Innate
-
11.1.1 Innate Company Details
-
11.1.2 Innate Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Innate Natural Killer Cell Therapies Main Business and Markets Served
-
11.1.4 Innate Natural Killer Cell Therapies Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Fortress Biotech
-
11.2.1 Fortress Biotech Company Details
-
11.2.2 Fortress Biotech Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Fortress Biotech Natural Killer Cell Therapies Main Business and Markets Served
-
11.2.4 Fortress Biotech Natural Killer Cell Therapies Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Dragonfly Therapeutics
-
11.3.1 Dragonfly Therapeutics Company Details
-
11.3.2 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Dragonfly Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
11.3.4 Dragonfly Therapeutics Natural Killer Cell Therapies Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 NantWorks
-
11.4.1 NantWorks Company Details
-
11.4.2 NantWorks Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 NantWorks Natural Killer Cell Therapies Main Business and Markets Served
-
11.4.4 NantWorks Natural Killer Cell Therapies Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Nkarta Therapeutics
-
11.5.1 Nkarta Therapeutics Company Details
-
11.5.2 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Nkarta Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
11.5.4 Nkarta Therapeutics Natural Killer Cell Therapies Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Affimed
-
11.6.1 Affimed Company Details
-
11.6.2 Affimed Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Affimed Natural Killer Cell Therapies Main Business and Markets Served
-
11.6.4 Affimed Natural Killer Cell Therapies Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Chipscreen Biosciences
-
11.7.1 Chipscreen Biosciences Company Details
-
11.7.2 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Chipscreen Biosciences Natural Killer Cell Therapies Main Business and Markets Served
-
11.7.4 Chipscreen Biosciences Natural Killer Cell Therapies Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Glycostem
-
11.8.1 Glycostem Company Details
-
11.8.2 Glycostem Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Glycostem Natural Killer Cell Therapies Main Business and Markets Served
-
11.8.4 Glycostem Natural Killer Cell Therapies Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Fate Therapeutics
-
11.9.1 Fate Therapeutics Company Details
-
11.9.2 Fate Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Fate Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
11.9.4 Fate Therapeutics Natural Killer Cell Therapies Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Kiadis Pharma
-
11.10.1 Kiadis Pharma Company Details
-
11.10.2 Kiadis Pharma Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Kiadis Pharma Natural Killer Cell Therapies Main Business and Markets Served
-
11.10.4 Kiadis Pharma Natural Killer Cell Therapies Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Nektar Therapeutics
-
11.11.1 Nektar Therapeutics Company Details
-
11.11.2 Nektar Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Nektar Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
11.11.4 Nektar Therapeutics Natural Killer Cell Therapies Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Natural Killer Cell Therapies Market Outlook by Types and Applications to 2028
-
12.1 Global Natural Killer Cell Therapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global NK Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global NK Cell Directed Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Natural Killer Cell Therapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Natural Killer Cell Therapies Market Analysis and Outlook to 2028
-
13.1 Global Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.2.2 Canada Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.2.3 Mexico Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.2 UK Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.3 Spain Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.4 Belgium Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.5 France Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.6 Italy Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.7 Denmark Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.8 Finland Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.9 Norway Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.10 Sweden Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.11 Poland Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.12 Russia Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.3.13 Turkey Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.2 Japan Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.3 India Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.4 South Korea Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.8 Thailand Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.9 Singapore Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.11 Philippines Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5.2 Colombia Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5.3 Chile Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5.4 Argentina Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5.6 Peru Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.6.3 Oman Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.6.4 Qatar Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.7.2 South Africa Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.7.3 Egypt Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.7.4 Algeria Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Natural Killer Cell Therapies Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Natural Killer Cell Therapies Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Natural Killer Cell Therapies
-
Figure of Natural Killer Cell Therapies Picture
-
Table Global Natural Killer Cell Therapies Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Natural Killer Cell Therapies Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global NK Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global NK Cell Directed Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Table North America Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Figure United States Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Canada Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Mexico Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Table Europe Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Figure Germany Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure UK Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Spain Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Belgium Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure France Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Italy Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Denmark Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Finland Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Norway Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Sweden Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Poland Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Russia Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Turkey Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Table APAC Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Figure China Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Japan Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure India Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Thailand Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Singapore Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Philippines Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Table South America Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Figure Brazil Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Colombia Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Chile Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Argentina Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Peru Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Table GCC Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Figure Bahrain Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Oman Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Qatar Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Table Africa Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Figure Nigeria Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Africa Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Egypt Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure Algeria Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Table Oceania Natural Killer Cell Therapies Consumption by Country (2017-2022)
-
Figure Australia Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Natural Killer Cell Therapies Consumption and Growth Rate (2017-2022)
-
Table Innate Company Details
-
Table Innate Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innate Natural Killer Cell Therapies Main Business and Markets Served
-
Table Innate Natural Killer Cell Therapies Product Portfolio
-
Table Fortress Biotech Company Details
-
Table Fortress Biotech Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fortress Biotech Natural Killer Cell Therapies Main Business and Markets Served
-
Table Fortress Biotech Natural Killer Cell Therapies Product Portfolio
-
Table Dragonfly Therapeutics Company Details
-
Table Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dragonfly Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
Table Dragonfly Therapeutics Natural Killer Cell Therapies Product Portfolio
-
Table NantWorks Company Details
-
Table NantWorks Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table NantWorks Natural Killer Cell Therapies Main Business and Markets Served
-
Table NantWorks Natural Killer Cell Therapies Product Portfolio
-
Table Nkarta Therapeutics Company Details
-
Table Nkarta Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nkarta Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
Table Nkarta Therapeutics Natural Killer Cell Therapies Product Portfolio
-
Table Affimed Company Details
-
Table Affimed Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affimed Natural Killer Cell Therapies Main Business and Markets Served
-
Table Affimed Natural Killer Cell Therapies Product Portfolio
-
Table Chipscreen Biosciences Company Details
-
Table Chipscreen Biosciences Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chipscreen Biosciences Natural Killer Cell Therapies Main Business and Markets Served
-
Table Chipscreen Biosciences Natural Killer Cell Therapies Product Portfolio
-
Table Glycostem Company Details
-
Table Glycostem Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glycostem Natural Killer Cell Therapies Main Business and Markets Served
-
Table Glycostem Natural Killer Cell Therapies Product Portfolio
-
Table Fate Therapeutics Company Details
-
Table Fate Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fate Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
Table Fate Therapeutics Natural Killer Cell Therapies Product Portfolio
-
Table Kiadis Pharma Company Details
-
Table Kiadis Pharma Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kiadis Pharma Natural Killer Cell Therapies Main Business and Markets Served
-
Table Kiadis Pharma Natural Killer Cell Therapies Product Portfolio
-
Table Nektar Therapeutics Company Details
-
Table Nektar Therapeutics Natural Killer Cell Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nektar Therapeutics Natural Killer Cell Therapies Main Business and Markets Served
-
Table Nektar Therapeutics Natural Killer Cell Therapies Product Portfolio
-
Figure Global NK Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NK Cell Directed Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Table North America Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Figure United States Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Figure Germany Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Figure China Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Figure Brazil Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Natural Killer Cell Therapies Consumption Forecast by Country (2022-2028)
-
Figure Australia Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Natural Killer Cell Therapies Consumption Forecast and Growth Rate (2022-2028)
-
